ENTITY

Sichuan Kelun-Biotech Biopharmaceutical (6990 HK)

113
Analysis
Health Care • China
Sichuan Kelun-Biotech Biopharmaceutical is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative biological and small molecule drugs, particularly Antibody-Drug Conjugates (ADCs). It addresses unmet medical needs in oncology, autoimmune disorders, and metabolic diseases, with key products including sacituzumab tirumotecan and trastuzumab botidotin. The company is headquartered in Chengdu, Sichuan, China, and was founded in 2016.
more
Company Event • 22 Mar 2027 20:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 17 Aug 2026 20:00 • Latest

H1 2026

Company Event • 23 Mar 2026 20:00

H2 2025

Company Event • 16 Jan 2026 01:30

44th Annual J.P. Morgan Healthcare Conference

Company Event • 18 Aug 2025 20:00

H1 2025

x